Evolution of the Average Target: Exor N.V.

Evolution of the Average Target - Exor N.V.

Evolution of the Target Price: Exor N.V.

Evolution of the Target Price - Exor N.V.

Changes in Analyst Recommendations: Exor N.V.

41c2.Y6zZcC2eOcujS_cTSAgByMYyjzBp0hmN5qNiD7eW50o.MN2rFUrSWpnHO8B5LEtt_rZC9XxE_ynlhfINftCgvQMPz-oeXcYKlOQPug~ad74cf7309b81f1c675ef912681ba958
03/09 AlphaValue/Baader Europe Updates EPS Forecasts for Exor on Expected Dividend Income MT
02/09 Exor: EPS upgrade (2025: +45.4%, 2026: +54.0%) Alphavalue
16/02 AlphaValue/Baader Europe Adjusts Exor Earnings Estimates After Stellantis' Preliminary H2 2025 Results MT
13/02 Exor: EPS cut (2025: -34.6%, 2026: -29.4%) Alphavalue
26/25/26 Exor: Exor H1 2025: Strategy still in waiting Alphavalue
17/25/17 The day the Fed resumed its rate cuts Zonebourse
02/25/02 Exor: Target upgrade by 17.8% Alphavalue
27/25/27 Exor: Exor's strategic moves: Market lagging behind Alphavalue
26/25/26 BNP Paribas Exane Upgrades Exor to Outperform MT
03/24/03 Exor: Adjustments following Exor's reclassification as an Investment Entity Alphavalue
02/24/02 Exor: Stellantis' woes likely to spill over to Exor Alphavalue
02/24/02 KBC Securities Starts Exor at Buy MT
25/24/25 Exor: NAV progresses further Alphavalue
23/24/23 AlphaValue/Baader Europe Upgrades Exor to Buy, Raises PT MT
23/24/23 Exor: Opinion change, from Add to Buy Alphavalue
11/24/11 Exor: Stellantis and Ferrari continue to push Exor forward Alphavalue
05/24/05 Exor: Exor is adept for recovery bets Alphavalue
19/24/19 Exor: NAV cut by -8.8% Alphavalue
01/23/01 Exor : Exor reiterates its faith in Philips Alphavalue
14/23/14 Exor : Exor pushes the throttle Alphavalue
16/23/16 Exor : Exor delivers on its diversification strategy Alphavalue
03/23/03 Exor : EPS upgrade (2022: -20.5%, 2023: +13.5%) Alphavalue
30/23/30 Analysts recommendations: Alliant Energy, Coinbase, Constellation Brands, Medtronic... Zonebourse
17/23/17 Exor : 2022: Another milestone year in Exor's Equity Story Alphavalue
19/23/19 Exor : All eyes on Juventus with Exor and Stellantis potentially impacted Alphavalue

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+41%
+31.97%
+4.23%
+13.61%
+24.35%
+13.81%
+20.42%
+25.43%
+15.21%
+23.6%
Average +21.36%
Weighted average by Cap. +20.82%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
73.25EUR
Average target price
103.29EUR
Spread / Average Target
+41.00%
High Price Target
120.00EUR
Spread / Highest target
+63.82%
Low Price Target
89.00EUR
Spread / Lowest Target
+21.50%

Analyst Consensus Detail

Analyst consensus - Exor N.V.

Consensus revision (last 18 months)

Consensus revision (last 18 months) - Exor N.V.
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
MarketScreener Ratings - Exor N.V.